Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
PRP does, however, carry something none of the peptides can match: a substantial human evidence base
Key findings from this phase 2 obesity trial included: Mean weight reduction of up to approximately 24.2% at the highest dose (12 mg) after 48 weeks Dose-dependent reductions in body weight across all active treatment arms Significant reductions in waist circumference, blood pressure, and lipid parameters Improvements in fasting glucose and insulin resistance markers A separate phase 2 trial in adults with type 2 diabetes (published in 2023) demonstrated meaningful HbA1c reductions alongside substantial weight loss, suggesting potential dual utility in both obesity and glycaemic management
GLP-1 therapy can be effective when hormonal and metabolic shifts are the main drivers of the weight gain
The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures
The pro-cognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-Met system
How long do you have to stay on semaglutide
US$ 28.00
US$ 23.63
US$ 23.70
